Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hypertension

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 132 articles:
HTML format
Text format



Single Articles


    January 2020
  1. ANDERSEN K, Hallmarker U, James S, Sundstrom J, et al
    Long-Distance Skiing and Incidence of Hypertension: A Cohort Study of 206,889 Participants in a Long-Distance Cross-Country Skiing Event.
    Circulation. 2020 Jan 6. doi: 10.1161/CIRCULATIONAHA.119.042208.
    PubMed     Text format     Abstract available


  2. GERGES C, Gerges M, Friewald R, Fesler P, et al
    Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Circulation. 2020 Jan 3. doi: 10.1161/CIRCULATIONAHA.119.041515.
    PubMed     Text format     Abstract available


  3. KONG D, Wan Q, Li J, Zuo S, et al
    DP1 Activation Reverses Age-Related Hypertension via NEDD4L-Mediated T-bet Degradation in T Cells.
    Circulation. 2020 Jan 2. doi: 10.1161/CIRCULATIONAHA.119.042532.
    PubMed     Text format     Abstract available


    November 2019
  4. PANDEY A, Patel KV, Vongpatanasin W, Ayers C, et al
    Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043337.
    PubMed     Text format    


    October 2019
  5. PENG J, Vongpatanasin W, Sacharidou A, Kifer D, et al
    Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
    Circulation. 2019 Oct 10. doi: 10.1161/CIRCULATIONAHA.119.043490.
    PubMed     Text format     Abstract available



  6. Correction to: Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2019;140:e718.
    PubMed     Text format    


  7. RUOPP NF, Farber HW
    The New World Symposium on Pulmonary Hypertension Guidelines: Should Twenty-One Be the New Twenty-Five?
    Circulation. 2019;140:1134-1136.
    PubMed     Text format    


    September 2019
  8. SUPIANO MA, Williamson JD
    New Guidelines and SPRINT Results: Implications for Geriatric Hypertension.
    Circulation. 2019;140:976-978.
    PubMed     Text format    


  9. COCKBAIN B, Price LC, Hind M
    Bony Breathlessness: Reversible Pulmonary Hypertension in Melnick-Needles Syndrome Using Noninvasive Ventilation
    Circulation. 2019;140:880-885.
    PubMed     Text format    


    August 2019
  10. TIAN W, Jiang X, Sung YK, Shuffle E, et al
    Phenotypically-Silent Bone Morphogenetic Protein Receptor 2 (Bmpr2) Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing The Risk for Neointimal Transformation.
    Circulation. 2019 Aug 29. doi: 10.1161/CIRCULATIONAHA.119.040629.
    PubMed     Text format     Abstract available


  11. NAEIJE R, Chin K
    Differentiating Precapillary From Postcapillary Pulmonary Hypertension.
    Circulation. 2019;140:712-714.
    PubMed     Text format    


  12. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
    Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
    Circulation. 2019;140:705-707.
    PubMed     Text format    


  13. NADEAU V, Bonnet S, Paulin R
    Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e286-e287.
    PubMed     Text format    


  14. MENDES-FERREIRA P, Manaud G, Perros F
    Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Circulation. 2019;140:e288-e289.
    PubMed     Text format    


    June 2019
  15. GILL D, Georgakis MK, Koskeridis F, Jiang L, et al
    Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects.
    Circulation. 2019 Jun 25. doi: 10.1161/CIRCULATIONAHA.118.038814.
    PubMed     Text format     Abstract available


    May 2019
  16. KIM B, Arany Z
    Does Glycine cataBOLAsm Drive Pulmonary Hypertension?
    Circulation. 2019;139:2256-2259.
    PubMed     Text format    


    April 2019
  17. JAMERSON KA
    Should Certain Antihyperglycemic Medications Be Preferred Over Antihypertensive Medications for Blood Pressure Control in Special Populations With Diabetes Mellitus?
    Circulation. 2019;139:2110-2112.
    PubMed     Text format    


  18. FERDINAND KC, Balavoine F, Besse B, Black HR, et al
    Efficacy and Safety of Firibastat, a First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins A Phase 2, Open-Label, Multicenter, Dose-Titrating Study.
    Circulation. 2019 Apr 24. doi: 10.1161/CIRCULATIONAHA.119.040070.
    PubMed     Text format     Abstract available


  19. MARON BA, Ryan JJ
    A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine.
    Circulation. 2019;139:1861-1864.
    PubMed     Text format    


  20. CHIN KM, Rubin LJ, Channick R, Di Scala L, et al
    Association of NT-proBNP and Long-Term Outcome in Patients with Pulmonary Arterial Hypertension: Insights from the Phase III GRIPHON Study.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039360.
    PubMed     Text format     Abstract available


    March 2019
  21. AZIZI M, Schmieder RE, Mahfoud F, Weber MA, et al
    Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451.
    PubMed     Text format     Abstract available


  22. COVASSIN N, Somers VK
    From Resistant Airway to Resistant Hypertension.
    Circulation. 2019;139:1285-1288.
    PubMed     Text format    


  23. JOHNSON DA, Thomas SJ, Abdalla M, Guo N, et al
    Association Between Sleep Apnea and Blood Pressure Control Among Blacks.
    Circulation. 2019;139:1275-1284.
    PubMed     Text format     Abstract available


    February 2019
  24. FERDINAND KC, Izzo JL, Lee J, Meng L, et al
    Antihyperglycemic and Blood Pressure Effects of Empagliflozin in African Americans with Type 2 Diabetes and Hypertension.
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.036568.
    PubMed     Text format     Abstract available


  25. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    PubMed     Text format     Abstract available


  26. YU Q, Tai YY, Tang Y, Zhao J, et al
    BOLA3 Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.035889.
    PubMed     Text format     Abstract available


    January 2019
  27. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    PubMed     Text format    


  28. SCHOMBURG L, Melander O
    Letter by Schomburg and Melander Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:722-723.
    PubMed     Text format    


  29. KIKUCHI N, Satoh K, Saito Y, Shimokawa H, et al
    Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".
    Circulation. 2019;139:724-725.
    PubMed     Text format    


  30. RAM CVS
    Status of Renal Denervation Therapy for Hypertension.
    Circulation. 2019;139:601-603.
    PubMed     Text format    



  31. Correction to: Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2019;139:e3.
    PubMed     Text format    



  32. Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    PubMed     Text format    


  33. FERDINAND KC, Graham RM
    Uncontrolled Hypertension in Black Men.
    Circulation. 2019;139:20-23.
    PubMed     Text format    


  34. VICTOR RG, Blyler CA, Li N, Lynch K, et al
    Sustainability of Blood Pressure Reduction in Black Barbershops.
    Circulation. 2019;139:10-19.
    PubMed     Text format     Abstract available


  35. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    PubMed     Text format     Abstract available


    December 2018
  36. YUAN K, Shamskhou EA, Orcholski ME, Nathan A, et al
    Loss of Endothelial Derived WNT5A is Associated with Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Circulation. 2018 Dec 11. doi: 10.1161/CIRCULATIONAHA.118.037642.
    PubMed     Text format     Abstract available


  37. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Text format     Abstract available


    November 2018
  38. KARIO K, Okada K, Kato M, Nishizawa M, et al
    24-Hour Blood Pressure-Lowering Effect of an SGLT-2 Inhibitor in Patients with Diabetes and Uncontrolled Nocturnal Hypertension: Results from the Randomized, Placebo-Controlled SACRA Study.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.037076.
    PubMed     Text format     Abstract available


  39. KIM HC, Jeon YW, Heo ST
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines.
    Circulation. 2018;138:2312-2314.
    PubMed     Text format    


    October 2018
  40. FUDIM M, Jones WS
    New Curveball for Hypertension Guidelines?
    Circulation. 2018;138:1815-1818.
    PubMed     Text format    


  41. WRIGHT JT JR, Carey RM, Bolen SD
    First-Year Anniversary of the 2017 Hypertension Guideline.
    Circulation. 2018;138:1774-1776.
    PubMed     Text format    


  42. BAI G, Bennet C, Wang J, Anderson GF, et al
    Access to Antihypertensive Drugs in China.
    Circulation. 2018;138:1777-1779.
    PubMed     Text format    


  43. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Text format     Abstract available


  44. HAUTEFORT A, Mendes-Ferreira P, Sabourin J, Manaud G, et al
    Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Circulation. 2018 Oct 4. doi: 10.1161/CIRCULATIONAHA.118.033744.
    PubMed     Text format     Abstract available


  45. YANG X, Zhang R, Wang D
    Letter by Yang et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1488-1489.
    PubMed     Text format    


  46. SCHIAVON CA, Ikeoka D, Santucci EV, Santos RN, et al
    Response by Schiavon et al to Letters Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1492-1493.
    PubMed     Text format    


  47. MORIS D, Cerullo M, Guerron AD
    Letter by Moris et al Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".
    Circulation. 2018;138:1490-1491.
    PubMed     Text format    


  48. MARQUES FZ
    Missing Heritability of Hypertension and Our Microbiome.
    Circulation. 2018;138:1381-1383.
    PubMed     Text format    


    September 2018
  49. FENGLER K, Rommel KP, Blazek S, Besler C, et al
    A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension (RADIOSOUND-HTN).
    Circulation. 2018 Sep 25. doi: 10.1161/CIRCULATIONAHA.118.037654.
    PubMed     Text format     Abstract available


    August 2018
  50. BONNET S, Paulin R, Boucherat O
    Small SeP or Giant Leap for Pulmonary Hypertension Research?
    Circulation. 2018;138:624-626.
    PubMed     Text format    


    May 2018
  51. HADINNAPOLA C, Graf S, Morrell NW
    Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2413-2414.
    PubMed     Text format    


  52. HERNANDEZ-GONZALEZ I, Navas P, Escribano-Subias P
    Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
    Circulation. 2018;137:2411-2412.
    PubMed     Text format    


  53. WHITE RJ, Wilkins MR
    New Therapeutic Approaches in Pulmonary Arterial Hypertension: The Pantheon Is Getting Crowded.
    Circulation. 2018;137:2390-2392.
    PubMed     Text format    


  54. CAMPBELL NRC, Zhang XH
    Hypertension in China: Time to Transition From Knowing the Problem to Implementing the Solution.
    Circulation. 2018;137:2357-2359.
    PubMed     Text format    


  55. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    PubMed     Text format     Abstract available


  56. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    PubMed     Text format    


    April 2018
  57. DE LA SIERRA A, Banegas JR, Vinyoles E, Segura J, et al
    Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.
    Circulation. 2018 Apr 30. pii: CIRCULATIONAHA.118.034619.
    PubMed     Text format     Abstract available


  58. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    PubMed     Text format    


  59. KIKUCHI N, Satoh K, Kurosawa R, Yaoita N, et al
    Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.
    Circulation. 2018 Apr 10. pii: CIRCULATIONAHA.117.033113.
    PubMed     Text format     Abstract available


    March 2018
  60. SOLIMAN EZ, Ambrosius WT, Lewis CE
    Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1300-1301.
    PubMed     Text format    


  61. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1299.
    PubMed     Text format    


  62. LEWIS GA, Schelbert EB, Miller CA
    Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1297-1298.
    PubMed     Text format    


  63. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    PubMed     Text format    


  64. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    PubMed     Text format    


  65. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    PubMed     Text format    


  66. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    PubMed     Text format    


  67. NADRUZ W JR, Claggett B, Henglin M, Shah AM, et al
    Widening Racial Differences in Risks for Coronary Heart Disease.
    Circulation. 2018;137:1195-1197.
    PubMed     Text format    


    February 2018
  68. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    PubMed     Text format    


  69. MANCIA G, Corrao G
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Italy.
    Circulation. 2018;137:889-890.
    PubMed     Text format    


  70. BRUNSTROM M, Carlberg B, Lindholm LH
    Perspective From Sweden on the Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A "Sprint" Beyond Evidence in the United States.
    Circulation. 2018;137:886-888.
    PubMed     Text format    


  71. SCHIFFRIN EL
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Canada.
    Circulation. 2018;137:883-885.
    PubMed     Text format    


  72. WANG Z, Chen Z, Zhang L, Wang X, et al
    Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015.
    Circulation. 2018 Feb 15. pii: CIRCULATIONAHA.117.032380.
    PubMed     Text format     Abstract available


  73. DUMAS SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, et al
    NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.029930.
    PubMed     Text format     Abstract available


  74. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    PubMed     Text format    


  75. COOPER R
    Hypertension, Genes, and Environment: Challenges for Prevention and Risk Prediction.
    Circulation. 2018;137:662-664.
    PubMed     Text format    


  76. WANDER GS, Ram CVS
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.
    Circulation. 2018;137:549-550.
    PubMed     Text format    


  77. WANG JG, Liu L
    Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.
    Circulation. 2018;137:546-548.
    PubMed     Text format    


  78. KARIO K
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.
    Circulation. 2018;137:543-545.
    PubMed     Text format    


  79. CHEN KH, Dasgupta A, Lin J, Potus F, et al
    Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Circulation. 2018 Feb 5. pii: CIRCULATIONAHA.117.031258.
    PubMed     Text format     Abstract available


    January 2018
  80. SUGLIA SF, Koenen KC, Boynton-Jarrett R, Chan PS, et al
    Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association.
    Circulation. 2018;137:e15-e28.
    PubMed     Text format     Abstract available


  81. HSU S, Kokkonen-Simon KM, Kirk JA, Kolb TM, et al
    Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.033147.
    PubMed     Text format     Abstract available


  82. JACKSON SL, Cogswell ME, Zhao L, Terry AL, et al
    Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults in the United States: National Health and Nutrition Examination Survey, 2014.
    Circulation. 2018;137:237-246.
    PubMed     Text format     Abstract available


  83. ZANCHETTI A, Thomopoulos C
    Benefits and Risks of Antihypertensive Treatment: How Far Can Diastolic Blood Pressure Be Lowered?
    Circulation. 2018;137:144-147.
    PubMed     Text format    


  84. MUNTNER P, Carey RM, Gidding S, Jones DW, et al
    Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Circulation. 2018;137:109-118.
    PubMed     Text format     Abstract available


  85. BEDDHU S, Chertow GM, Cheung AK, Cushman WC, et al
    Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Circulation. 2018;137:134-143.
    PubMed     Text format     Abstract available


  86. BOYD HA, Basit S, Wohlfahrt J, Oyen N, et al
    Response by Boyd et al to Letter Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:97-98.
    PubMed     Text format    


  87. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:95-96.
    PubMed     Text format    


    December 2017
  88. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    PubMed     Text format    


  89. PAZOKI R, Dehghan A, Evangelou E, Warren H, et al
    Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations with Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2017 Dec 18. pii: CIRCULATIONAHA.117.030898.
    PubMed     Text format     Abstract available


  90. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    PubMed     Text format     Abstract available


  91. KALKMAN DN, Brouwer TF, Vehmeijer JT, Berger WR, et al
    J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Circulation. 2017;136:2220-2229.
    PubMed     Text format     Abstract available


    November 2017
  92. CAILLON A, Huo KG, Paradis P, Schiffrin EL, et al
    Response by Caillon et al to Letter Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2200-2201.
    PubMed     Text format    


  93. CAMPBELL DJ
    Letter by Campbell Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2198-2199.
    PubMed     Text format    


  94. KOSKINEN J, Juonala M, Dwyer T, Venn A, et al
    Impact of Lipid Measurements in Youth in Addition to Conventional Clinic-Based Risk Factors on Predicting Preclinical Atherosclerosis in Adulthood: The International Childhood Cardiovascular Cohort (i3C) Consortium.
    Circulation. 2017 Nov 23. pii: CIRCULATIONAHA.117.029726.
    PubMed     Text format     Abstract available


  95. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    PubMed     Text format     Abstract available


  96. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    PubMed     Text format    


  97. SCHIAVON CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, et al
    Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032130.
    PubMed     Text format     Abstract available


  98. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Text format     Abstract available


    October 2017
  99. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    PubMed     Text format     Abstract available


  100. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    PubMed     Text format     Abstract available


  101. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    PubMed     Text format     Abstract available


    September 2017
  102. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    PubMed     Text format     Abstract available


  103. NIIRANEN TJ, Larson MG, McCabe EL, Xanthakis V, et al
    Prognosis of Prehypertension Without Progression to Hypertension.
    Circulation. 2017;136:1262-1264.
    PubMed     Text format    


  104. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    PubMed     Text format     Abstract available


  105. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    PubMed     Text format     Abstract available


  106. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    PubMed     Text format     Abstract available


  107. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    PubMed     Text format     Abstract available


    August 2017
  108. LI H, Cai J, Chen R, Zhao Z, et al
    Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification.
    Circulation. 2017;136:618-627.
    PubMed     Text format     Abstract available


  109. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    PubMed     Text format     Abstract available



  110. Correction to: Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Circulation. 2017;136:e136.
    PubMed     Text format    


    July 2017
  111. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Text format     Abstract available


    June 2017
  112. STERGIOU GS, Ntineri A, Kollias A
    Defining Ambulatory Blood Pressure Thresholds for Decision Making in Hypertension: The Effect of Race and Methodology.
    Circulation. 2017;135:2481-2484.
    PubMed     Text format    


  113. RAVENELL J, Shimbo D, Booth JN 3rd, Sarpong DF, et al
    Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Circulation. 2017;135:2470-2480.
    PubMed     Text format     Abstract available


  114. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    PubMed     Text format     Abstract available


  115. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    PubMed     Text format    


  116. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    PubMed     Text format    


    May 2017
  117. SAG CM, Schnelle M, Zhang J, Murdoch CE, et al
    Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
    Circulation. 2017;135:2163-2177.
    PubMed     Text format     Abstract available


  118. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    PubMed     Text format    


  119. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    PubMed     Text format     Abstract available


    April 2017
  120. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    PubMed     Text format     Abstract available


  121. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    PubMed     Text format    


  122. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    PubMed     Text format     Abstract available


  123. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    PubMed     Text format     Abstract available


    March 2017
  124. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    PubMed     Text format     Abstract available


  125. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    PubMed     Text format     Abstract available


  126. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    PubMed     Text format     Abstract available


    January 2017
  127. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Text format     Abstract available


    November 2016
  128. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  129. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    PubMed     Text format     Abstract available


  130. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    PubMed     Text format     Abstract available


    October 2016
  131. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


    August 2016
  132. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: